Dr. Kaushal Ippili is a highly skilled neurologist and neurosciences specialist based in Hyderabad, India, currently practicing at Apollo Health City, Jubilee Hills. With over 15 years of dedicated experience in the field of neurosciences, Dr. Ippili brings extensive clinical expertise in the diagnosis and management of a wide range of neurological conditions, including epilepsy, multiple sclerosis, movement disorders, and neuromuscular diseases. His comprehensive approach to neurological care makes him a trusted choice for patients seeking advanced treatment options. Dr. Ippili has built a distinguished career spanning multiple reputable institutions and is recognized for his clinical proficiency in managing complex neurological disorders. He holds particular expertise in epilepsy management — including drug-resistant and pediatric epilepsy — as well as cerebrovascular diseases, peripheral neuropathy, and movement disorders such as Parkinson's disease and dystonia. His dedication to advancing neurological care is reflected in his research contributions, including published work on regenerative therapies for neurodegenerative disorders. For international patients seeking expert neurological care in India, Dr. Ippili offers a combination of deep clinical experience, multidisciplinary collaboration, and a patient-centered approach within one of Hyderabad's premier healthcare institutions.
- Neurology
- Epilepsy Treatment
- Drug-Resistant Epilepsy
- Parkinson's Disease
- Dystonia Management
- Tremor Disorders Management
- Stroke Treatment & Recovery
- Multiple Sclerosis (MS)
- Myasthenia Gravis
- Alzheimer's Disease / Dementia
- Diabetic Neuropathy
- Migraine / Chronic Headache
- MBBS
- MS (General Medicine)
- DNB (Neurology)
- Apollo Health City, Jubilee Hills, Hyderabad
- AP Medical Council
- Medical Council of India
- NSI (Neurological Society of India)
- APNSA
- University Topper in MD
- Principal investigator and contributor to research in regenerative therapies, including published work on "Intravenous Infusion of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Regenerative Dyssynergia Pluralis: An Outcome Monitoring Clinical Pilot Study in Degenerative Disorders"
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.